Peer-reviewedCC BY-NC-NDHepatology communications14 Oct 2026

Molecular biomarkers for diagnosis, prognosis, precision therapy, and immunotherapy in cholangiocarcinoma, cHCC-CCA, and HCC

Jingguo Sun¹
Yingjie Lu¹
Lu Chang¹
Ruiqun Gao¹
Ming Guan¹
Haoyu Ruan²
Xuan Deng¹

¹Department of Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai, China
²Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study
Kazuki Obara, Shorena Janelidze, Daisuke Ito +16
eBioMedicine1 Oct 2026Peer-reviewedCC BY 4.01 citedNeurologyCrossref
Mitoxyperilysis-based molecular subtyping identifies SPP1+ macrophages and IL1B as critical mediators of tumor progression and immunotherapy resistance in intrahepatic cholangiocarcinoma
Yafei Wang, Kai Ding, Jiale Niu +2
Journal of Translational Medicine1 Aug 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaDOAJ
Identification of CRF-related molecular subtypes and a prognostic CRRS model in glioma: insights into immunotherapy response prediction and candidate biomarkers
Jihao Xue, Jianguo Xu, Qijia Yin +1
Scientific Reports28 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Human geneticsCrossref
Integrated Molecular Classification of Endometrial Cancer: Impact on Diagnosis, Prognosis, and Clinical Management—A Systematic Review
Silvio Antonio Galeano Reyes, María Eugenia Fraile Bethencourt, Serena Lacerenza +6
Cancers1 Oct 2026Peer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefEurope PMC
Integrated Bile Metabolomics and Serum Biomarkers for Differentiating Cholangiocarcinoma from Cholelithiasis
Jinduo Zhang, Leiqing Wang, Xu Zhang +8
Biomedicines1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{sun2026molecular,
  title = {{Molecular biomarkers for diagnosis, prognosis, precision therapy, and immunotherapy in cholangiocarcinoma, cHCC-CCA, and HCC}},
  author = {Jingguo Sun and Yingjie Lu and Lu Chang and Ruiqun Gao and Ming Guan and Haoyu Ruan and Xuan Deng},
  journal = {Hepatology communications},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13668292},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Molecular biomarkers for diagnosis, prognosis, precision therapy, and immunotherapy in cholangiocarcinoma, cHCC-CCA, and HCC
AU  - Jingguo Sun
AU  - Yingjie Lu
AU  - Lu Chang
AU  - Ruiqun Gao
AU  - Ming Guan
AU  - Haoyu Ruan
AU  - Xuan Deng
PY  - 2026
DA  - 2026/10/14
JO  - Hepatology communications
UR  - https://europepmc.org/article/PMC/PMC13668292
SN  - 2471-254X
ER  -

Related

Cite